Lumos Pharma Inc. buy DomRuinart
Start price
11.01.21
/
50%
€18.00
Target price
11.01.22
€25.00
Performance (%)
-17.22%
End price
25.01.21
€14.90
Summary
This prediction ended on 25.01.21 with a price of €14.90. The price of Lumos Pharma Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.22%. DomRuinart has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Lumos Pharma Inc. | - | - | - | - |
iShares Core DAX® | -0.116% | 1.953% | 14.155% | 16.268% |
iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% | 43.377% |
iShares Nikkei 225® | -1.721% | 3.263% | 12.922% | 8.501% |
iShares S&P 500 | -1.527% | 0.194% | 27.117% | 41.752% |
According to DomRuinart what are the pros and cons of Lumos Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread NewLink Genetics Corp diskutieren
Buy mit Kursziel 25,0
In the thread Trading Lumos Pharma Inc.
Buy beendet